SEC and FDA Sign Memorandum of Understanding
The U.S. Securities and Exchange Commission (SEC) and the Food and Drug Administration (FDA) have signed a memorandum of understanding to enhance cooperation between their agencies. This agreement aims to support both organizations' missions: ensuring market integrity for the SEC, and protecting public health for the FDA. The collaboration is expected to facilitate information sharing and coordinated efforts where financial markets intersect with healthcare regulation. The MOU reflects growing recognition among regulatory bodies of the need for cross-sector cooperation in an increasingly complex economic environment.
Topics: FDA financial markets memorandum of understanding public health SEC